Litcius/Paper detail

CD73 as a target to improve temozolomide chemotherapy effect in glioblastoma preclinical model

Juliana H. Azambuja, Roselena Silvestri Schuh, Luana Roberta Michels, Nicolly Espíndola Gelsleichter, Liziane Raquel Beckenkamp, Gabriela Spies Lenz, Francine Hehn de Oliveira, Michaël Wink, Marco Antônio Stefani, Ana Maria Oliveira Battastini, Hélder Ferreira Teixeira, Elizandra Braganhol

2020Cancer Chemotherapy and Pharmacology33 citationsDOI

Topics & Concepts

TemozolomideIn vivoGliomaPharmacologyChemotherapyMedicineViability assaySmall interfering RNACancer researchDoxorubicinAdenosineIn vitroChemistryCell cultureBiologyInternal medicineTransfectionBiochemistryGeneticsBiotechnologyAdenosine and Purinergic SignalingRNA Interference and Gene DeliveryNanoparticle-Based Drug Delivery
CD73 as a target to improve temozolomide chemotherapy effect in glioblastoma preclinical model | Litcius